4th International Conference and Exhibition on Pharmacovigilance & Clinical Trials
August 10-12, 2015 London, UK

Theme: Reviving Strategies for Safer Therapeutics in Healthcare System

The field of Pharmacovigilance & Clinical trials is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Pharmacovigilance-2015  emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Main theme of is Pharmacovigilance-2015 is “Reviving Strategies for Safer Therapeutics in Healthcare System".

UK proves to be perfect location for production, research and sales of world-class pharmaceuticals. UK ranks sixth in the pharmaceutical marketing and is home for GlaxoSmithKline and AstraZeneca. A new method (developed by the industry-based Office of Health Economics (OHE)) of projecting drug spending in the UK forecasts that the total market will show annual growth rates of 3.1%-4.1% to 2015, while sales in the branded segment will increase 0.5%-1.8% a year and total generics sales will grow 10%-11% yearly over the period.

Select your language of interest to view the total content in your interested language
Share This Article
Browse Conferences
2014 Conferences
2015 Conferences
Region-wise Conferences
Conference Destination Map
Previous Conferences
Subject wise
Open Access Journals
Clinical Journals
Chemistry Journals
Engineering Journals
Environmental Journals
Life Sciences Journals
Management Journals
Medical Sciences Journals
OMICS Journals
Pharmaceutical Sciences Journals
Follow Us   RSS  Facebook  Twitter  Blog  Linkedin  You tube  Google Plus  Pintrest  Flickr  Slide Share
About Us | Open Access | Open Access Journals | OMICS Group Conferences | International Collaborations | Scientific Credits | Membership | Submit Manuscript | OMICS Publishing Group
Manuscript Submission & Tracking System | Open Access Publishing | Open Access Publication
Copyright © 2014 OMICS Group, All Rights Reserved.